Overview

A First-in-Human Study of Enteral Drug Delivery Device

Status:
Not yet recruiting
Trial end date:
2019-07-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to ascertain the efficacy and short-term safety of the RaniPill in healthy volunteers
Phase:
Phase 1
Details
Lead Sponsor:
RANI Therapeutics
Collaborator:
Nucleus Network Ltd
Treatments:
Octreotide